Dementias Platform UK secures £2.2 million funding from the Alzheimer’s Disease Data Initiative
16 February 2023
The funding will support DPUK's work in bridging the gaps between discoveries in the lab, trials and new treatments for dementia.
New funding awarded to study persistent pain in inflammatory arthritis
25 March 2022
Major Funding Awards Strategic Developments
The £3.9M Wellcome Collaborative Award will be used to identify the drivers of pain in people living with rheumatoid arthritis.
NIHR Awards Oxford Health Clinical Research Facility £4 million Over Next Five Years
7 March 2022
Major Funding Awards Strategic Developments
The Oxford Health Clinical Research Facility (OH CRF) is one of 28 facilities across England to benefit from nearly £161 million that has been awarded by the National Institute for Health Research (NIHR) to expand early phase clinical research delivery in NHS hospitals.
Christoph Treiber awarded ERC Starting Grant to investigate the origins of behavioural diversity
10 January 2022
Congratulations are in order for postdoctoral research scientist Dr Christoph Treiber who has been awarded a Starting Grant from the European Research Council. His funded project will investigate the genetic components that may contribute to diversity of brain function and behaviour.
Funding received for research into Motor Neuron Disease
5 January 2022
A £210,000 donation from the Alan Davidson Foundation has been made to the Nuffield Department of Clinical Neurosciences to advance our world-leading research into Motor Neuron Disease. The funding will support a project manager to deliver an innovative research project using the genetic causes of MND to develop approaches to early diagnosis.
Major research network to investigate body clock and stroke
27 October 2021
Major Funding Awards Research Highlights Strategic Developments
The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.
Mapping uncharted networks in the progression of Parkinson’s
27 October 2021
Major Funding Awards Strategic Developments
A major new $9 million project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. The project is a collaboration between a core team of Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Mark Howe at Boston University and Dinos Meletis at the Karolinska Institute, as well as collaborators Yulong Li at Peking University and Michael Lin at Stanford University.
Researchers awarded Wellcome Innovator Grant to investigate role of brainstem nucleus in human consciousness
25 October 2021
Major Funding Awards Strategic Developments
Researchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in human consciousness.
£36 Million Boost for AI Technologies to Revolutionise NHS Care
24 June 2021
Major Funding Awards Research Highlights Strategic Developments
An Oxford project using artificial intelligence to develop digital triage tools for mental health clinicians (CHRONOS) is one of 38 projects support by the second wave of the NHS AI Lab's AI in Health and Care Award.
£9 million investment for health and social care research
30 July 2019
Major Funding Awards Strategic Developments
The NIHR Applied Research Collaboration for Oxford and Thames Valley will launch in October 2019. It is one of 15 ARC's across England, each will work with local and national partners to address some of the nation’s most pressing challenges faced by the health and care system over the next 5 years, including dementia, obesity and mental health.
World’s largest autism grant will transform research landscape
25 June 2018
Major Funding Awards Research Highlights
The largest research grant ever given for neurodevelopmental conditions has been awarded by the Innovative Medicines Initiative to an international consortium academically led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London.